nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—Penbutolol—HTR1B—attention deficit hyperactivity disorder	0.0102	0.473	CrCbGaD
Alprenolol—Pindolol—HTR1B—attention deficit hyperactivity disorder	0.00732	0.341	CrCbGaD
Alprenolol—Propranolol—HTR1B—attention deficit hyperactivity disorder	0.00399	0.186	CrCbGaD
Alprenolol—ADRB3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00129	0.00132	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00129	0.00132	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00129	0.00132	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00127	0.00129	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00127	0.00129	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00124	0.00127	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00124	0.00126	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00123	0.00126	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00121	0.00124	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00121	0.00124	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00121	0.00123	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0012	0.00123	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00118	0.0012	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00118	0.0012	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00116	0.00119	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00115	0.00118	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00115	0.00118	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00114	0.00117	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00114	0.00116	CbGpPWpGaD
Alprenolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00113	0.00116	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00113	0.00116	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00113	0.00115	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00113	0.00115	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00112	0.00114	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0011	0.00113	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0011	0.00112	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00109	0.00112	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00109	0.00112	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00109	0.00111	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00107	0.0011	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00107	0.00109	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00107	0.00109	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00106	0.00108	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00106	0.00108	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00105	0.00108	CbGpPWpGaD
Alprenolol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00105	0.00107	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00105	0.00107	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00104	0.00107	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00104	0.00106	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00104	0.00106	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00103	0.00105	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00104	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00101	0.00104	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00101	0.00103	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00101	0.00103	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000996	0.00102	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00099	0.00101	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000988	0.00101	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000986	0.00101	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000985	0.00101	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000984	0.00101	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000969	0.00099	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000968	0.000989	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000964	0.000986	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00096	0.000981	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000958	0.000979	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000947	0.000967	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000937	0.000958	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000937	0.000958	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000917	0.000937	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000917	0.000937	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000908	0.000928	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000897	0.000916	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000892	0.000912	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000888	0.000907	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000881	0.000901	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000878	0.000898	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000873	0.000892	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000868	0.000887	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000862	0.000881	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000859	0.000878	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000853	0.000872	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000843	0.000861	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00084	0.000859	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000836	0.000855	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000821	0.000839	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000803	0.000821	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000785	0.000802	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000769	0.000786	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000768	0.000785	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000759	0.000776	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000751	0.000767	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000738	0.000754	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000734	0.00075	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000731	0.000747	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000731	0.000747	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000716	0.000732	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000715	0.000731	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000714	0.000729	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000701	0.000716	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000699	0.000715	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000698	0.000714	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000691	0.000706	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000685	0.0007	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000683	0.000698	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00068	0.000694	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000679	0.000694	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000676	0.000691	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000671	0.000686	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000671	0.000686	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000665	0.000679	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000664	0.000678	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000664	0.000678	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000661	0.000676	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000661	0.000675	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000658	0.000673	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000656	0.000671	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000656	0.000671	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00065	0.000665	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00065	0.000664	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000649	0.000664	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000647	0.000661	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000647	0.000661	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000642	0.000656	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000642	0.000656	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000639	0.000653	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000636	0.00065	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000635	0.000649	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000635	0.000649	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000625	0.000639	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000622	0.000636	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000617	0.000631	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000612	0.000625	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000598	0.000611	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000598	0.000611	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000595	0.000608	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000587	0.0006	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000585	0.000597	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00058	0.000593	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000575	0.000588	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000572	0.000584	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000562	0.000575	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000562	0.000574	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000559	0.000571	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000558	0.00057	CbGpPWpGaD
Alprenolol—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000554	0.000566	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00055	0.000562	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000541	0.000552	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000509	0.00052	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000496	0.000507	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000486	0.000496	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000475	0.000485	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000456	0.000466	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000451	0.000461	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000449	0.000458	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000446	0.000456	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000441	0.000451	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000438	0.000447	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000437	0.000446	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000434	0.000443	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000431	0.000441	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000428	0.000438	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000424	0.000434	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000419	0.000428	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000417	0.000426	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000415	0.000424	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000403	0.000412	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000395	0.000403	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000394	0.000403	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000392	0.000401	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000392	0.000401	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000391	0.000399	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000386	0.000394	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000385	0.000394	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000384	0.000393	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000384	0.000392	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000384	0.000392	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000382	0.000391	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000379	0.000388	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000379	0.000387	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000377	0.000385	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000377	0.000385	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000376	0.000384	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000376	0.000384	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000375	0.000383	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000374	0.000382	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000371	0.000379	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000369	0.000377	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000367	0.000376	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000367	0.000375	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000366	0.000374	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000365	0.000373	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000363	0.000371	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00036	0.000368	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000358	0.000366	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000355	0.000363	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000353	0.000361	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000353	0.000361	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00035	0.000358	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000349	0.000356	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000347	0.000355	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000347	0.000355	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000346	0.000353	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000344	0.000352	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000343	0.00035	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000341	0.000349	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000339	0.000347	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000338	0.000345	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000337	0.000344	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000334	0.000341	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000329	0.000337	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000321	0.000328	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000319	0.000326	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000314	0.000321	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000307	0.000314	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000266	0.000272	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00026	0.000266	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000255	0.00026	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000247	0.000253	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000242	0.000247	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000237	0.000242	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000233	0.000238	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00023	0.000235	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000228	0.000233	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000225	0.00023	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000224	0.000229	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000223	0.000228	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00022	0.000225	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000216	0.000221	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000215	0.00022	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000212	0.000216	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00021	0.000214	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000207	0.000212	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000206	0.000211	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000205	0.000209	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000203	0.000208	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000201	0.000206	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.0002	0.000205	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000199	0.000203	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000197	0.000201	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000195	0.000199	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00019	0.000194	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000185	0.000189	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000181	0.000185	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000159	0.000162	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000159	0.000162	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000156	0.000159	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000145	0.000148	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000133	0.000136	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00013	0.000133	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000127	0.00013	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000127	0.00013	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000121	0.000123	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000118	0.000121	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	9.61e-05	9.82e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.54e-05	9.75e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.03e-05	7.19e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.88e-05	7.03e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.73e-05	6.87e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	4.12e-05	4.21e-05	CbGpPWpGaD
